Search
for
Sort by
Research 661–690 of 1000+
- The Thyroid Hormone Analogue KB2115 (Eprotirome) Prolongs Human Hair Growth (Anagen) Ex Vivo
- Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Novel <i>ABCD1</i> Gene Mutation in Adrenomyeloneuropathy with Hypoplasia and Agenesis of the Corpus Callosum
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- The eosinophilia-myalgia syndrome
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- Hypothyroidism in Dogs
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- A Phytochemical and Pharmacological Review on <i>Cynomorium songaricum</i> as Functional and Medicinal Food
- Cult of the Body Beautiful: At What Cost?
- Biological effects of human placental extracts - variations in manufacturing methods and compositions
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Reversing Time with Peptides: Mechanisms, Classifications, and Innovations in Anti-aging Interventions
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Comprehensive analysis of differences in cashmere production performance in Liaoning cashmere goats by using metabolomics and transcriptomics
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Satoyoshi Syndrome: Difficult to find or treat?
- Evidence for the off-label use of tofacitinib in alopecia areata
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program